Expert consensus-based medication-use evaluation criteria for atypical antipsychotic drugs

American Journal of Health-System Pharmacy

Volumn 60, Issue 23, 2003, Pages 2455-2470

  Love, Raymond C ^a   Mackowick, Marie ^a   Carpenter, Daniel ^b   Burks, Emalie J ^c  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b Univ S Carolina Sch Med Vice P   (United States)

^c JANSSEN RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Antipsychotic agents; Clozapine; Combined therapy; Data collection; Drug use; Methodology; Olanzapine; Quetiapine; Rational therapy; Risperidone; Ziprasidone

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; DECANOIC ACID DERIVATIVE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

AGITATION; BIPOLAR DISORDER; CONSENSUS; COST EFFECTIVENESS ANALYSIS; DELIRIUM; DELUSIONAL DISORDER; DRUG INDICATION; DRUG USE; HEALTH SURVEY; HEART DISEASE; HUMAN; MAJOR DEPRESSION; MEDICAL CARE; MEDICAL DECISION MAKING; MEDICAL EXPERT; PERSONALITY DISORDER; PHARMACIST; PRIORITY JOURNAL; PSYCHIATRIST; PSYCHOSIS; RATING SCALE; REVIEW; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCORING SYSTEM; ARTICLE; COMPARATIVE STUDY; DRUG THERAPY; MONITORING; PRACTICE GUIDELINE; QUESTIONNAIRE; STANDARD; STATISTICS; UNITED STATES;

ANTIPSYCHOTIC AGENTS; DRUG THERAPY; HUMANS; MONITORING, PHYSIOLOGIC; PRACTICE GUIDELINES; QUESTIONNAIRES; UNITED STATES;

EID: 1542649762     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/60.23.2455     Document Type: Review

References (24)

1. Accreditation manual for hospitals. Chicago, IL: Joint Commission on Accreditation of Healthcare Organizations; 1996.
2. Concepts in managed care pharmacy: drug use evaluation. Alexandria, VA: The Academy of Managed Care Pharmacy; 1999 Jun 12.
3. American Society of Health-System Pharmacists. ASHP guidelines on medication-use evaluation. Am J Health-Syst Pharm. 1996; 53:1953-5.
4. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990; 47:533-43.
5. American Society of Hospital Pharmacists. ASHP statement on pharmaceutical care. Am J Hosp Pharm. 1993; 50: 1720-3.
6. Shepski JC, Wincor MZ, Gutierrez MA et al. Development and implementation of drug use evaluation (DUE) criteria for risperidone in an outpatient psychiatric setting. Psychopharmacol Bull. 1996; 32: 705-19.
7. Edgell ET, Summers KH, Hylan TR et al. A framework for drug utilization evaluation in depression: insights from outcomes research. Med Care. 1999; 37 (suppl 4):AS67-76.
8. Nadzam DM. Development of medication-use indicators by the Joint Commission on Accreditation of Healthcare Organizations. Am J Hosp Pharm. 1991; 48: 1925-30.
9. Knapp DA. Development of criteria for drug utilization review. Clin Pharmacol Ther. 1991; 50:600-2.
10. Djulbegovic B, Hadley T. Evaluating the quality of clinical guidelines. Linking decisions to medical evidence. Oncology. 1998; 12:310-4.
11. Shekelle PG, Kahan JP, Bernstein SJ et al. The reproducibility of a method to identify the overuse and underuse of medical procedures. N Engl J Med. 1998; 338: 1888-95.
12. Frances A, Kahn D, Carpenter D et al. A new method of developing expert consensus practice guidelines. Am J Manag Care. 1998; 4:1023-9.
13. Kahn DA, Carpenter D, Docherty JP et al. The expert consensus guideline series: treatment of bipolar disorder. J Clin Psychiatry. 1996; 57(suppl 12a):1-88.
14. McEvoy JP, Weiden PJ, Smith TE et al. The expert consensus guideline series: treatment of schizophrenia. J Clin Psychiatry. 1996; 57(suppl 12b):1-58.
15. March JS, Frances A, Carpenter D et al. The expert consensus guideline series: treatment of obsessive-compulsive disorder. J Clin Psychiatry. 1997; 58(suppl 4):1-72.
16. Alexopoulos GS, Silver JM, Kahn DA et al. The expert consensus guideline series: treatment of agitation in older persons with dementia. Postgrad Med Spec Rep. 1998; (Apr):1-88.
17. McEvoy JP, Scheifler PL, Frances A. The expert consensus guideline series: treatment of schizophrenia 1999. J Clin Psychiatry. 1999; 60(suppl 11):1-80.
18. Foa EB, Davidson JR, Frances A. The expert consensus guideline series: treatment of posttraumatic stress disorder. J Clin Psychiatry. 1999; 60(suppl 16):1-76.
19. Sachs GS, Printz DJ, Kahn DA et al. The expert consensus guideline series: medication treatment of bipolar disorder 2000. Postgrad Med Spec Rep. 2000; (Apr):1-104.
20. Expert consensus guideline series: treatment of psychiatric and behavioral problems in mental retardation. Am J Ment Retard. 2000; 105:159-228.
21. Altshuler LL, Cohen LS, Moline ML et al. The expert consensus guideline series: treatment of depression in women 2001. Postgrad Med Spec Rep. 2001; (Mar):1-116.
22. Kahn DA, Docherty JP, Carpenter D et al. Consensus methods in practice guideline development: a review and description of a new method. Psychopharmacol Bull. 1997; 33:631-9.
23. Brook RH, Chassin MR, Fink A et al. A method for the detailed assessment of the appropriateness of medical technologies. Int J Technol Assess Health Care. 1986; 2: 53-63.
24. Angaran DM. Quality assurance to quality improvement: measuring and monitoring pharmaceutical care. Am J Hosp Pharm. 1991; 48:1901-7.